Annovis Bio, Inc.

Pharmaceutical company · Malvern, Pennsylvania, United States · NYSE: ANVS

Annovis Bio, Inc. is a pharmaceutical company headquartered in Malvern, Pennsylvania, United States. Its earliest recorded incorporation is in 2008. Its shares trade on NYSE under the ticker ANVS. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $913,507 in total, most recently in 2013. It has reported private securities offerings to the US SEC, most recently $1.1 million sold in a notice filed in 2023.

www.annovisbio.comProfile compiled from public records. Is this your company? Request a correction or update

Annovis Bio at a glance

Typepharmaceutical company
HeadquartersMalvern, Pennsylvania, United States
Earliest incorporation on record2008
Stock listingNYSE: ANVS
SEC industryPharmaceutical Preparations
Employees (per SBIR records)12
SEC CIK1477845

What does Annovis Bio do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $913,507 in total (2010 to 2013).

Private fundraising reported to the SEC

10 Form D notices; the most recent reported $1.1 million sold (2023).

Frequently asked questions about Annovis Bio

Where is Annovis Bio headquartered?

Annovis Bio, Inc. is headquartered in Malvern, Pennsylvania, United States.

What does Annovis Bio do?

Annovis Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Annovis Bio a public company?

Yes. Annovis Bio, Inc. trades on NYSE under the ticker ANVS.

When was Annovis Bio founded?

The earliest incorporation on record for Annovis Bio, Inc. is in 2008, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.

Annovis Bio: Headquarters, Locations & Company Profile (2026) | BioBridgeX